Toxins

Anesthesiology Clinics of North America

Volumn 24, Issue 3, 2006, Pages 647-670

  Sather, John E ^a   Tantawy, Hossam ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMYL NITRITE; BENZOCAINE; BENZODIAZEPINE; BUPIVACAINE; CALCIUM OXALATE; CARBON MONOXIDE; CHLORATE; CHLOROQUINE; COCAINE; DEXTROPROPOXYPHENE; DIAMORPHINE; ETHYLENE GLYCOL; FENTANYL; GLYCERYL TRINITRATE; LIDOCAINE; METHADONE; METHANOL; METOCLOPRAMIDE; MORPHINE; NALOXONE; NITROUS OXIDE; OPIATE; ORAL ANTIDIABETIC AGENT; PETHIDINE; PHENYTOIN; SODIUM CHANNEL BLOCKING AGENT; TOXIN; TRAMADOL; UNINDEXED DRUG;

COUGHING; DELIRIUM; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; HUMAN; KIDNEY DISEASE; METHEMOGLOBINEMIA; NEUROTOXICITY; NONHUMAN; RESPIRATION DEPRESSION; REVIEW; SCLERODERMA; SEIZURE; THERMAL INJURY; THORAX PAIN; TREMOR; VASOCONSTRICTION; VISUAL IMPAIRMENT;

ALCOHOLISM; CARBON MONOXIDE POISONING; COCAINE; COCAINE-RELATED DISORDERS; CYANIDES; HUMANS; METHEMOGLOBINEMIA; OPIOID-RELATED DISORDERS; OPIUM; STREET DRUGS;

EID: 33748766856     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atc.2006.05.001     Document Type: Review

References (64)

1. Fingerhut L.A., and Cox C.S. Poisoning mortality, 1985-1995. Public Health Rep 113 3 (1998) 218-233
2. Toxicology in ECC. Circulation 112 24 Suppl (2005) IV126-IV132
3. Watson W.A., Litovitz T.L., Rodgers Jr. G.C., et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 23 5 (2005) 589-666
4. Substance Abuse and Mental Health Services Administration, OoAS. Emergency department trends from the drug abuse warning network, final estimates. DAWN Series D-24 (2003) 1-148
5. Qureshi A.I., et al. Cocaine use and the likelihood of nonfatal myocardial infarction and stroke: data from the Third National Health and Nutrition Examination Survey. Circulation 103 4 (2001) 502-506
6. Levine M., et al. The effects of cocaine and heroin use on intubation rates and hospital utilization in patients with acute asthma exacerbations. Chest 128 4 (2005) 1951-1957
7. Marzuk P.M., et al. Fatal injuries after cocaine use as a leading cause of death among young adults in New York City. N Engl J Med 332 26 (1995) 1753-1757
8. Soderstrom C.A., et al. Epidemic increases in cocaine and opiate use by trauma center patients: documentation with a large clinical toxicology database. J Trauma 51 3 (2001) 557-564
9. Musto D.F. A study in cocaine. Sherlock Holmes and Sigmund Freud. JAMA 204 1 (1968) 27-32
10. Gay G.R., et al. Cocaine: history, epidemiology, human pharmacology, and treatment. A perspective on a new debut for an old girl. Clin Toxicol 8 2 (1975) 149-178
11. Shanti C.M., and Lucas C.E. Cocaine and the critical care challenge. Crit Care Med 31 6 (2003) 1851-1859
12. Boghdadi M.S., and Henning R.J. Cocaine: pathophysiology and clinical toxicology. Heart Lung 26 6 (1997) 466-483 [quiz: 484-5]
13. Hollander J.E., and Henning R. Cocaine. In: Goldfrank L.R. (Ed). Goldfrank's toxicologic emergencies. 7th edition (2002), McGraw-Hill, New York 1004-1014
14. Lange R.A., and Hillis L.D. Cardiovascular complications of cocaine use. N Engl J Med 345 5 (2001) 351-358
15. Hollander J.E., et al. Chest pain associated with cocaine: an assessment of prevalence in suburban and urban emergency departments. Ann Emerg Med 26 6 (1995) 671-676
16. Karch S.B. Cocaine cardiovascular toxicity. South Med J 98 8 (2005) 794-799
17. Frishman W.H., et al. Cardiovascular manifestations of substance abuse part 1: cocaine. Heart Dis 5 3 (2003) 187-201
18. Rich J.A., and Singer D.E. Cocaine-related symptoms in patients presenting to an urban emergency department. Ann Emerg Med 20 6 (1991) 616-621
19. Daras M. Neurologic complications of cocaine. NIDA Res Monogr 163 (1996) 43-65
20. Kaufman M.J., et al. Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA 279 5 (1998) 376-380
21. Haim D.Y., et al. The pulmonary complications of crack cocaine. A comprehensive review. Chest 107 1 (1995) 233-240
22. Crowe A.V., et al. Substance abuse and the kidney. QJM 93 3 (2000) 147-152
23. Whittington R.A., et al. Dexmedetomidine increases the cocaine seizure threshold in rats. Anesthesiology 97 3 (2002) 693-700
24. Shih R.D., et al. Clinical safety of lidocaine in patients with cocaine-associated myocardial infarction. Ann Emerg Med 26 6 (1995) 702-706
25. Hoffman R.S., et al. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice. J Pharmacol Exp Ther 263 2 (1992) 698-702
26. Kambam J.R., et al. In vitro effects of fluoride and bromide on pseudocholinesterase and acetylcholinesterase activities. Can J Anaesth 37 8 (1990) 916-919
27. Jatlow P., et al. Cocaine and succinylcholine sensitivity: a new caution. Anesth Analg 58 3 (1979) 235-238
28. Nelson L.S. Opioids. In: Goldfrank L.R. (Ed). Goldfrank's toxicologic emergencies. 7th edition (2002), McGraw-Hill, New York 901-922
29. Meldrum M.L. A capsule history of pain management. JAMA 290 18 (2003) 2470-2475
30. Miller R.J., and Tran P.B. More mysteries of opium revealed: 300 years of opiates. Trends Pharmacol Sci 21 8 (2000) 299-304
31. Sneader W. The discovery of heroin. Lancet 352 9141 (1998) 1697-1699
32. Gutstein HB. Opioid analgesics. In: Brunton LL, Parker KL, Buxton IL, et al, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 11th edition. New York: McGraw-Hill; 2006.
33. Sporer K.A. Acute heroin overdose. Ann Intern Med 130 7 (1999) 584-590
34. Mokhlesi B., et al. Adult toxicology in critical care: Part II: specific poisonings. Chest 123 3 (2003) 897-922
35. Duberstein J.L., and Kaufman D.M. A clinical study of an epidemic of heroin intoxication and heroin-induced pulmonary edema. Am J Med 51 6 (1971) 704-714
36. Sporer K.A., and Dorn E. Heroin-related noncardiogenic pulmonary edema: a case series. Chest 120 5 (2001) 1628-1632
37. Clarke S.F., Dargan P.I., and Jones A.L. Naloxone in opioid poisoning: walking the tightrope. Emerg Med J 22 9 (2005) 612-616
38. Cygan J., Trunsky M., and Corbridge T. Inhaled heroin-induced status asthmaticus: five cases and a review of the literature. Chest 117 1 (2000) 272-275
39. Krantz A.J., et al. Heroin insufflation as a trigger for patients with life-threatening asthma. Chest 123 2 (2003) 510-517
40. Frishman W.H., et al. Cardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine. Heart Dis 5 4 (2003) 253-271
41. Riker R.R., and Fraser G.L. Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy 25 5 Pt 2 (2005) 8S-18S
42. Gil M., et al. QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone. Am J Cardiol 92 8 (2003) 995-997
43. Vallee B.L. Alcohol in the western world. Sci Am 278 6 (1998) 80-85
44. Barceloux D.G., et al. American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Ethylene Glycol Poisoning. Ad Hoc Committee. J Toxicol Clin Toxicol 37 5 (1999) 537-560
45. Yip L. Ethanol. In: Goldfrank L.R. (Ed). Goldfrank's toxicologic emergencies. 7th edition (2002), McGraw-Hill, New York 952-962
46. Sharma A. Toxic alcohols. In: Goldfrank L.R. (Ed). Goldfrank's toxicologic emergencies. 7th edition (2002), McGraw-Hill, New York 980-989
47. Barceloux D.G., et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol 40 4 (2002) 415-446
48. Jacobsen D. New treatment for ethylene glycol poisoning. N Engl J Med 340 11 (1999) 879-881
49. Brent J., et al. Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group. N Engl J Med 340 11 (1999) 832-838
50. Brent J., et al. Fomepizole for the treatment of methanol poisoning. N Engl J Med 344 6 (2001) 424-429
51. Stewart R.D. The effect of carbon monoxide on humans. Annu Rev Pharmacol 15 (1975) 409-423
52. Ernst A., and Zibrak J.D. Carbon monoxide poisoning. N Engl J Med 339 22 (1998) 1603-1608
53. Norkool D.M., and Kirkpatrick J.N. Treatment of acute carbon monoxide poisoning with hyperbaric oxygen: a review of 115 cases. Ann Emerg Med 14 12 (1985) 1168-1171
54. Weaver L.K., et al. Carboxyhemoglobin half-life in carbon monoxide-poisoned patients treated with 100% oxygen at atmospheric pressure. Chest 117 3 (2000) 801-808
55. Weaver L.K., et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 347 14 (2002) 1057-1067
56. Weaver L.K., and Churchill S. Pulmonary edema associated with hyperbaric oxygen therapy. Chest 120 4 (2001) 1407-1409
57. Cummings T.F. The treatment of cyanide poisoning. Occup Med (Lond) 54 2 (2004) 82-85
58. Way J.L. Cyanide intoxication and its mechanism of antagonism. Annu Rev Pharmacol Toxicol 24 (1984) 451-481
59. Delaney K. Cyanide. In: Ford M.D. (Ed). Clinical toxicology. 1st edition (2001), W.B. Saunders, Philadelphia 705-710
60. Michenfelder J.D. Cyanide release from sodium nitroprusside in the dog. Anesthesiology 46 3 (1977) 196-201
61. Baud F.J., et al. Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit Care Med 30 9 (2002) 2044-2050
62. Groeper K., Katcher K., and Tobias J.D. Anesthetic management of a patient with methemoglobinemia. South Med J 96 5 (2003) 504-509
63. Wright R.O., Lewander W.J., and Woolf A.D. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med 34 5 (1999) 646-656
64. Barker S.J., Tremper K.K., and Hyatt J. Effects of methemoglobinemia on pulse oximetry and mixed venous oximetry. Anesthesiology 70 1 (1989) 112-117